Peregrine Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

A detailed history of Peregrine Capital Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 1,147 shares of ALNY stock, worth $281,519. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,147

Previous 1,147 -0.0%

Holding current value

$281,519

Previous $278,000 13.31%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$138.54 - $232.0 $32,279 - $54,056	-233 Reduced 16.88%	1,147 $230,000
Q3 2020 Oct 20, 2020	SELL	$121.19 - $165.49 $11.3 Million - $15.5 Million	-93,386 Reduced 98.54%	1,380 $200,000
Q2 2020 Jul 30, 2020	SELL	$104.21 - $156.44 $1.45 Million - $2.18 Million	-13,909 Reduced 12.8%	94,766 $14 Million
Q1 2020 Apr 17, 2020	SELL	$93.12 - $133.99 $4.09 Million - $5.89 Million	-43,962 Reduced 28.8%	108,675 $11.8 Million
Q4 2019 Jan 16, 2020	SELL	$74.51 - $124.23 $2.88 Million - $4.8 Million	-38,648 Reduced 20.2%	152,637 $17.6 Million
Q3 2019 Oct 16, 2019	SELL	$70.9 - $87.82 $2.82 Million - $3.49 Million	-39,757 Reduced 17.21%	191,285 $15.4 Million
Q2 2019 Jul 18, 2019	BUY	$65.86 - $92.79 $2.49 Million - $3.51 Million	37,821 Added 19.57%	231,042 $0
Q1 2019 Apr 12, 2019	SELL	$72.76 - $93.45 $260,480 - $334,551	-3,580 Reduced 1.82%	193,221 $0
Q4 2018 Jan 17, 2019	SELL	$62.67 - $88.33 $77,522 - $109,264	-1,237 Reduced 0.62%	196,801 $14.3 Million
Q3 2018 Oct 18, 2018	BUY	$87.52 - $122.67 $1.7 Million - $2.38 Million	19,433 Added 10.88%	198,038 $0
Q2 2018 Jul 12, 2018	BUY	$88.31 - $107.8 $3.26 Million - $3.98 Million	36,886 Added 26.03%	178,605 $0
Q1 2018 Apr 16, 2018	SELL	$115.92 - $148.54 $774,345 - $992,247	-6,680 Reduced 4.5%	141,719 $0
Q4 2017 Jan 24, 2018	SELL	$114.49 - $139.98 $1.89 Million - $2.3 Million	-16,465 Reduced 9.99%	148,399 $0
Q3 2017 Oct 25, 2017	BUY	$72.53 - $118.27 $12 Million - $19.5 Million	164,864	164,864 $0

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History